Cyril Ramaphosa opens Patrick Soon-Shiong’s African vaccine headquarters
SA-born Soon-Shiong, founder of the multinational conglomerate NantWorks, established NantSA in Brackenfell
19 January 2022 - 11:52
by PHILANI NOMBEMBE
Support our award-winning journalism. The Premium package (digital only) is R30 for the first month and thereafter you pay R129 p/m now ad-free for all subscribers.
A technician at the Chan Soon-Shiong Centre for Epidemic Response and Innovation at Stellenbosch University on January 19 2022. Picture: GCIS/ELMOND JIYANE.
A manufacturing operation that will allow next-generation vaccines to be manufactured in SA for the rest of the continent was launched in Cape Town on Wednesday by President Cyril Ramaphosa.
Patrick Soon-Shiong, founder of the multinational conglomerate NantWorks, established NantSA in Brackenfell. The billionaire was born in SA and graduated from Wits University medical school.
Ramaphosa and Soon-Shiong also launched the Coalition to Accelerate Africa’s Access to Advanced Healthcare, which aims to drive the development of innovative therapeutics and ensure the continent is prepared for future pandemics.
Patrick Soon-Shiong with Stellenbosch University rector Wim de Villiers and higher education, science and technology minister Blade Nzimande, at the launch of the Chan Soon-Shiong Centre for Epidemic Response and Innovation on January 19 2022. Picture: GCIS/ELMOND JIYANE
Earlier on Wednesday, Soon-Shiong was at Stellenbosch University for the launch of the Chan Soon-Shiong Centre for Epidemic Response and Innovation.
The Chan Soon-Shiong Family Foundation is also supporting the establishment of institutes for infectious disease and cancer centres of excellence at the universities of Cape Town and the Witwatersrand.
Soon-Shiong runs NantWorks from Los Angeles and has signed a collaboration agreement with the CSIR and SA Medical Research Council (SAMRC).
Speakers at the launch in Brackenfell included Corey Casper, CEO of the Infectious Diseases Research Institute at the University of Washington in the US; Glenda Gray, president and CEO of the SAMRC; and John Nkengasong, director of the Africa Centres for Disease Control and Prevention.
Soon-Shiong holds more than 500 patents for cancer and infectious disease treatments and has invested in biotechnology and artificial intelligence start-ups.
Support our award-winning journalism. The Premium package (digital only) is R30 for the first month and thereafter you pay R129 p/m now ad-free for all subscribers.
Cyril Ramaphosa opens Patrick Soon-Shiong’s African vaccine headquarters
SA-born Soon-Shiong, founder of the multinational conglomerate NantWorks, established NantSA in Brackenfell
A manufacturing operation that will allow next-generation vaccines to be manufactured in SA for the rest of the continent was launched in Cape Town on Wednesday by President Cyril Ramaphosa.
Patrick Soon-Shiong, founder of the multinational conglomerate NantWorks, established NantSA in Brackenfell. The billionaire was born in SA and graduated from Wits University medical school.
Ramaphosa and Soon-Shiong also launched the Coalition to Accelerate Africa’s Access to Advanced Healthcare, which aims to drive the development of innovative therapeutics and ensure the continent is prepared for future pandemics.
Earlier on Wednesday, Soon-Shiong was at Stellenbosch University for the launch of the Chan Soon-Shiong Centre for Epidemic Response and Innovation.
The Chan Soon-Shiong Family Foundation is also supporting the establishment of institutes for infectious disease and cancer centres of excellence at the universities of Cape Town and the Witwatersrand.
Soon-Shiong runs NantWorks from Los Angeles and has signed a collaboration agreement with the CSIR and SA Medical Research Council (SAMRC).
Speakers at the launch in Brackenfell included Corey Casper, CEO of the Infectious Diseases Research Institute at the University of Washington in the US; Glenda Gray, president and CEO of the SAMRC; and John Nkengasong, director of the Africa Centres for Disease Control and Prevention.
Soon-Shiong holds more than 500 patents for cancer and infectious disease treatments and has invested in biotechnology and artificial intelligence start-ups.
Data for Moderna’s Omicron-specific vaccine will probably be available in March
Vaccine equity a must to end pandemic, WHO tells online Davos meeting
Boosters do not stop Omicron but still protect, SA-German study shows
Would you like to comment on this article?
Sign up (it's quick and free) or sign in now.
Please read our Comment Policy before commenting.
Most Read
Related Articles
PODCAST | The future of mandatory Covid-19 vaccination
‘Twindemic’ on the cards in Europe as flu makes a return
Jab mandates should not lead to job losses, says Nzimande
Published by Arena Holdings and distributed with the Financial Mail on the last Thursday of every month except December and January.